Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone pretreatment in older women undergoing first IVF/ICSI
ChiCTR2200063596Phase 4Not yet recruiting
- Sponsor
- Guangdong Women and Children Hospital
- Start
- Sep 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of somatropin in ovarian dysfunction and infertility (2 arms), sponsored by Guangdong Women and Children Hospital. Primary endpoint: Cumulative live birth rate. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
somatropin
03
Conditions
ovarian dysfunctioninfertility
Beyond the preview
Go deeper on ChiCTR2200063596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063596.